Masomeh Rabieepour

Masomeh Rabieepour

Auto-generated profile, based on publicly available information

Masomeh Rabieepour

Department of Medicine, College of Medicine, Urmia University of Medical Sciences, Urmia, Iran

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2015 in Advances in Respiratory Medicine
Verified
Journal Article
Open access
PDF file
MRMohammad Hossein Rahimi-Rad
Mohammad Hossein Rahimi-Rad
SSSheida Soltani
Sheida Soltani
MRMasome Rabieepour
Masome Rabieepour
SRShagayegh Rahimirad
Shagayegh Rahimirad
Introduction: Thrombocytopenia (TP) is associated with poor outcome in patients who are critically ill with pneumonia, burns, and H1N1 influenza. To our knowledge, no similar study in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) has been conducted to date. The aim of this study was to determine the impact of platelet count on the outcome of patients with AECOPD. Materials and Methods: Patients admitted to our teaching hospital for AECOPD were divided into two cohorts, those with and without TP. The outcome of all patients was followed. Results: Of the 200 patients with AECOPD, 55 (27.5%) had TP. Of these, 14 (25.5%) died in the hospital, whereas of the 145 non-TP patents, 11 (7.5%) died (p-value = 0.001). There was a significantly higher transfer rate to the ICU and mechanical ventilation in TP patients. The mean platelet count was significantly lower in patients who died than those who were discharged (161,672 vs. 203,005 cell/μL; p-value = 0.017). There was negative correlation between duration of hospitalization and platelet count. Conclusion: TP was associated with poor outcome in AECOPD. TP could be considered as a marker for the assessment of inflammation and prognosis in AECOPD patients based on its cost-effective features.

31 May 2022 in Immunopathologia Persa
Verified
Journal Article
Open access
AVAida Varghaei
Aida Varghaei
HMHengameh Mojdeganlou
Hengameh Mojdeganlou
MRMasomeh Rabieepour
Masomeh Rabieepour
AMAmir Mikaeilvand
Amir Mikaeilvand
AAAta Abbasi
Ata Abbasi
ILD is a common manifestation of dermatomyositis (DM) with indolent course but a unique variant of DM called clinically amyopathic DM (CADM) presents with rapid progressive interstitial lung disease (RP-ILD) and is called CADM associated RP-ILD. Here, we report a case of a 52 year old woman with CADM associated RP-ILD occurred 2 weeks after recovery from COVID19 infection but unfortunately died from RP-ILD, almost 5 months later. This is the first report of CADM associated RP-ILD triggered by COVID19 in an adult patient